Lyell Immunopharma, Inc. (LYEL) Presents at Stifel 2026 Healthcare Conference 2026 Transcript
Lyell: Upgrade To 'Buy' On Ronde-Cel Advancement LBCL And $80 Million Funding Boost
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2026
Lyell Immunopharma Q3 EPS $(1.86) Beats $(2.06) Estimate, Sales $3.000K Beat $2.333K Estimate
Loading...